STAT+: Early trial shows promise aiming a modified cold-sore virus against brain tumors in children
A therapy that sends a modified cold-sore virus to selectively kill tumor cells and spark…
Category: Biotech
STAT+: Clinical study reports hold more details about the side effects of cancer drugs
For years, researchers have urged regulators to release clinical study reports that are generated during…
Google is exploring a health record tool for patients
After 13 years, Google is coming back for patient health records. The tech giant has…
STAT+: Pharmalittle: Lilly arthritis drug failed main goal in Covid-19 study; Serum Institute asks India for a big grant to make Covid shots
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Natural killer cells, primed with an antibody, induce remissions in patients with advanced blood cancer
Two patients with advanced Hodgkin lymphoma were told their tumors were so resistant to treatment…
.jpg)
Opinion: Autism: awareness, acceptance, and the places in between
In its efforts to rebrand April, currently designated as Autism Awareness Month, the Autism Society…
Opinion: ‘It shouldn’t be this hard’ for foreign-trained health professionals to work in the U.S.
When people ask if they should call me “doctor,” I’ve always answered, “Please, call me…
Scientists work toward an elusive dream: a simple pill to treat Covid-19
The world has vaccines that can prevent most cases of Covid-19. It even has drugs…
AstraZeneca’s latest vaccine woes, the compassionate use dilemma, & what it’s like to give out Covid vaccines
What’s next for AstraZeneca? Are there any right answers when it comes to compassionate use?…
STAT+: Brazilian judge temporarily suspends pharmaceutical patent extensions amid push to lower drug costs
A Brazilian Supreme Court judge suspended extensions for pharmaceutical patents in the country, and although…
Virtual Event: What gene-targeted therapies mean for patients with cancer
Editors note: A livestream of the event will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: EMA finds link between AstraZeneca shot and rare blood clots; life science private financing is at record levels
Rise and shine, another busy day is on the way. However, this is also shaping…
STAT+: Digital pharmacy startup Thirty Madison taps former Lilly exec as president
After nearly three decades working at two of the world’s pharmaceutical giants, Michelle Carnahan is…
Opinion: STAT+: Unprecedented development of Covid-19 vaccines, treatments points to biopharma’s future
Business as usual has not been the mantra for companies developing Covid-19 vaccines and drugs….
Opinion: How humility can save us from Covid-19
“I was wrong.” That simple statement should have been at the top of the soundtrack…
STAT+: ‘Here to stay’: How the pandemic helped build a burgeoning home testing industry
Just a few years ago, the idea of at-home testing was practically antithetical to Caesar…
Biden officials rebuff appeals to surge Covid-19 vaccine to Michigan amid growing crisis
WASHINGTON — Amid Michigan’s worst-in-the-nation coronavirus surge, scientists and public health officials are urging the…
In the Covid-19 vaccine push, no one is speaking Gen Z’s language
WASHINGTON — Useful Covid-19 information isn’t reaching the Instagram generation. There’s almost no messaging specifically…
Judge rules Purdue must answer questions about documents showing any link between OxyContin, birth defects
A federal judge has given a green light to lawyers representing children with birth defects…
‘As good a model as I’ve seen’: MIT biologist on new initiative to address gender inequities in biotech
When Nancy Hopkins joined the faculty of the Massachusetts Institute of Technology nearly 50 years…
STAT+: Merck reaches deal with Austrian antitrust regulators over ‘predatory’ pricing for a cancer drug
Following a three-year probe, Merck (MRK) reached a deal with Austrian regulators to end a…
STAT+: How artificial intelligence could make clinical trials smarter
Clinical trials have a dirty little secret. For all the careful work that goes into…
In rare instances, AstraZeneca’s Covid-19 vaccine linked to blood clots, regulators say
The European Medicines Agency has concluded there is a link between AstraZeneca’s Covid-19 vaccine and…
STAT+: Massachusetts General Hospital president Peter Slavin to depart after 18 years
The president of Massachusetts General Hospital, Dr. Peter L. Slavin, plans to step down after…
STAT+: Pharmalittle: U.S. is prohibited from sharing Covid-19 shots with other countries; U.S. officials knew of problems at Emergent plant
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
Opinion: Listen: Antibiotic experts on the threat of antimicrobial resistant superbugs
This week’s “First Opinion Podcast” takes a look at antimicrobial resistance, a topic that should…
Akili’s therapeutic video game will be tested as a treatment for Covid ‘brain fog’
Akili, which made history last summer by earning regulatory clearance for the first video-game based…
Opinion: India shouldn’t insist on ‘bridging trials’ in the middle of a pandemic
India is facing a brutal second wave of Covid-19, with daily case counts approaching 100,000….
Opinion: A skeptic’s take on Neuralink and other consumer neurotech
The titans of Silicon Valley say that the brain-computer interface revolution is coming, and neurotech…
STAT+: Biotech venture capitalists have more money than ever to invest. What could possibly go wrong?
There’s more money sloshing around in biotech than ever before. Over the past year, several…
Covid-19 reinfections still seem rare, but the U.S. lacks good data
Reinfections from Covid-19 continue to seem rare, and are not responsible for the current, stubbornly…
STAT+: Fibrogen admits false heart-safety data for experimental anemia pill shared with FDA, investors
Fibrogen acknowledged Tuesday that the company has been touting false heart-safety data for its experimental…
1 in 3 Covid-19 patients are diagnosed with a neuropsychiatric condition in the next six months, large study finds
Six months after being diagnosed with Covid-19, 1 in 3 patients also had experienced a…
STAT+: A controversial court case in Brazil will tackle pharma ‘monopolies’ and access to drugs
After years of anticipation, the Brazilian Supreme Court is holding a hearing this week on…
STAT+: California once again delays launch of a closely watched prescription drug purchasing program
For the second time this year, California officials have delayed a much-ballyhooed effort to start…
Medical device firms’ payments to doctors far outstripped those from pharma, study shows
WASHINGTON — The medical device industry gave doctors consulting fees, lunches, lodging, and other incentive…
STAT+: MIT scientists launch Future Founders Initiative to solve biotech’s ‘missing women’ problem
A group of prominent MIT scientists that formed to address gender inequities in the biotech…
STAT+: Boston’s hospital chiefs moonlight on corporate boards at rates far beyond the national level
As chief of Boston Children’s Hospital, one of the most esteemed pediatric hospitals in the…
STAT+: STAT+ Conversations: A conversation on how to find that elusive Covid-19 vaccine
Editors note: A livestream of the conversation will be embedded below at 1:15 p.m. ET….
STAT+: Pharmalittle: EMA official says link exists between AstraZeneca Covid-19 shot and rare blood clots; Catalent to boost Moderna vaccine production
Top of the morning, and a fine one it is. Clear blue skies and a…
Opinion: To stem the pandemic, the U.S. needs a national Covid-19 genomic sequencing effort
More than a year into the pandemic, the United States is at yet another critical…
Opinion: Excited delirium: valid clinical diagnosis or medicalized racism? Organized medicine needs to take a stand
The “diagnosis” of excited delirium, a term often used to justify and defend police brutality,…
.jpg)
‘Who is going to protect me?’: Ratings app aims to remove bias from the birthing experiences of Black and brown mothers
Thirty weeks into my first pregnancy, I developed some concerning abdominal pain. The clinicians in…
STAT+: There’s no point person in Biden’s HHS for its $186 billion Covid-19 fund for health care providers
WASHINGTON — Health care providers are eagerly awaiting billions of dollars from a Covid-19 relief…
Troubling podcast puts JAMA, the ‘voice of medicine,’ under fire for its mishandling of race
Weeks after it was scrubbed from the Journal of the American Medical Association’s website, a…
STAT+: Lilly is a holdout among companies that agree to disclose when executive pay is clawed back
A coalition of institutional investors is pushing Eli Lilly to adopt a policy to disclose…
Opinion: Tax exemptions for nonprofit hospitals: It’s time taxpayers get their money’s worth
Many U.S. hospitals provide charity care to financially disadvantaged patients without the expectation of getting…
STAT+: Pharmalittle: U.S. puts J&J in charge of plant that botched Covid-19 vaccines; pharmacies offering Covid shots raise privacy concerns
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: FDA cites lack of evidence in rejecting Acadia Pharma’s bid to expand use of anti-psychosis drug
Acadia Pharmaceuticals said Monday that U.S. regulators had rejected its application seeking to expand the…
Opinion: ‘Authorization’ status is a red herring when it comes to mandating Covid-19 vaccination
Covid-19 vaccines offer a way out of the global crisis that has upended — and…